- Home
- UPLD vs SLS Comparison
UPLD vs SLS Comparison
Compare UPLD & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPLD
- SLS
- Stock Information
- Founded
- UPLD 2010
- SLS 2012
- Country
- UPLD United States
- SLS United States
- Employees
- UPLD N/A
- SLS N/A
- Industry
- UPLD Computer Software: Prepackaged Software
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- UPLD Technology
- SLS Health Care
- Exchange
- UPLD Nasdaq
- SLS Nasdaq
- Market Cap
- UPLD 67.6M
- SLS 70.1M
- IPO Year
- UPLD 2014
- SLS N/A
- Fundamental
- Price
- UPLD $3.84
- SLS $1.06
- Analyst Decision
- UPLD Hold
- SLS
- Analyst Count
- UPLD 3
- SLS 0
- Target Price
- UPLD $3.75
- SLS N/A
- AVG Volume (30 Days)
- UPLD 349.1K
- SLS 1.4M
- Earning Date
- UPLD 02-20-2025
- SLS 11-13-2024
- Dividend Yield
- UPLD N/A
- SLS N/A
- EPS Growth
- UPLD N/A
- SLS N/A
- EPS
- UPLD N/A
- SLS N/A
- Revenue
- UPLD $278,945,000.00
- SLS N/A
- Revenue This Year
- UPLD N/A
- SLS N/A
- Revenue Next Year
- UPLD N/A
- SLS N/A
- P/E Ratio
- UPLD N/A
- SLS N/A
- Revenue Growth
- UPLD N/A
- SLS N/A
- 52 Week Low
- UPLD $1.79
- SLS $0.50
- 52 Week High
- UPLD $5.64
- SLS $1.72
- Technical
- Relative Strength Index (RSI)
- UPLD 42.79
- SLS 55.79
- Support Level
- UPLD $3.76
- SLS $0.87
- Resistance Level
- UPLD $4.12
- SLS $1.01
- Average True Range (ATR)
- UPLD 0.35
- SLS 0.08
- MACD
- UPLD -0.12
- SLS 0.01
- Stochastic Oscillator
- UPLD 6.56
- SLS 73.08
About UPLD Upland Software Inc.
Upland Software Inc is a provider of cloud-based enterprise work management software. The company provides a family of cloud-based enterprise work management software applications for the information technology, process excellence, finance, professional services and marketing functions within organizations. It services customers ranging from corporations and Government agencies to small- and medium-sized businesses engaged in the field of financial services, retail, technology, manufacturing, education, consumer goods, media, and telecommunications, Government, food and beverage, healthcare and life sciences, chemicals and travel and hospitality. The products of the company are Altify, BA Insight, InGenius, Panviva, Qvidian, RightAnswers and others.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.